You are here:

Home
NICE Guidance
Conditions and diseases
Mental health, behavioural and neurodevelopmental conditions
Psychosis and schizophrenia

Psychosis and schizophrenia Products

A list of all our products on psychosis and schizophrenia

Filter

Product type

Product typeGuidanceQuality standardsAdvice

Guidance programme

Guidance programmeNICE guidelinesTechnology appraisal guidanceHealthTech guidance

Status
1 selected

StatusPublishedIn consultationIn developmentAwaiting developmentTopic prioritisation

New and updated

New and updatedNew in the last 6 months

Showing 1 product

Sort by: Date | Sort by Title

Status: In consultationRemove ‘Status: In consultation’ filter

Xanomeline tartrate–trospium chloride for treating schizophrenia ID6716
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
26 June 2026
Expected publication date:
TBC